Barrett Business Services heads into its May 6 Q1 earnings print with one striking development: short sellers have retreated at an unusually fast pace, even as options traders have become meaningfully more defensive.
The short-covering story is the standout this week. SI as a percentage of the free float collapsed from around 3.3% to 2.1% between April 22 and April 24 — a drop of roughly a third in two sessions. Over the full week, short interest fell 36%, one of the sharper single-week unwinds in recent months. Whether that reflects genuine conviction about the upcoming print or simply pre-earnings risk management is hard to disentangle, but the speed and size of the move is notable. Cost to borrow, at just under 1%, is cheap and has been roughly stable; availability remains ample, with borrow nowhere near constrained. The ORTEX short score has also eased to 31.1 from the mid-34s that held through most of April, reinforcing the picture of shorts stepping back. The setup is not one of squeeze pressure — it is one of orderly position reduction.
Options positioning tells a different story, and the contrast is worth flagging. The put/call ratio has climbed to 1.23, nearly double its 20-day average of 0.66 and running about 1.4 standard deviations above the mean. That points to heavier demand for downside protection in the run-up to earnings — traders are hedging even as pure short sellers are covering. The divergence between the two positioning signals is itself the most interesting feature of BBSI's pre-earnings setup this week.
Coverage is thin and recent analyst data is limited, but what exists tilts constructively. Barrington Research reiterated its Outperform rating and $41 target just this week — the only fresh action in the past two months. After cutting the target from $46 to $41 following the February earnings disappointment, the firm has since held firm. Roth Capital made the same February cut, moving to $42 from $54 while keeping a Buy rating. The mean target of around $42 implies roughly 34% upside to the current $31.49 close. Valuation is modest: the stock trades near 16x trailing earnings and around 9x EV/EBITDA. The EV/EBITDA factor score ranks in the 80th percentile relative to the broader universe, suggesting the market is not paying a premium multiple for BBSI right now.
The insider picture adds an important layer. CEO Gary Kramer bought 8,370 shares in mid-March at roughly $26.89, a purchase worth around $225,000. Director Mark Finn made four separate open-market purchases across March, accumulating another 3,500 shares between $27.88 and $29.40. Net insider buying over the past 90 days totals around $1.49 million. That cluster of buying — led by the CEO and reinforced by a board member — came after the stock fell hard following February results. Notably, Royce & Associates added over 500,000 shares in Q1, the largest institutional change in the top-holder list, bringing its stake to 5.6%.
The earnings history is stark. The last two prints produced first-day drops of 11.8% and 13.6%, with five-day drawdowns settling around 6–7%. Those reactions came after results that disappointed on guidance and revealed softness in client employee levels — the key volume driver for the professional employer organisation model. The bear case centres on that exact vulnerability: BBSI's PEO revenue concentration and its heavy California exposure leave it exposed to any further deterioration in SME employment conditions. The bull case rests on new client additions, healthcare segment growth, and a management team that is literally buying the stock with its own money. The EPS surprise factor score at the 71st percentile suggests the company has historically beaten estimates more often than not — but the last two quarters were notable exceptions.
What to watch on May 6 is simple: the trajectory of worksite employee counts and any commentary on client-level hiring conditions will determine whether the insider buying cluster looks prescient or premature.
See the live data behind this article on ORTEX.
Open BBSI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
